The United States of America on Thursday announced that blood sample of people who contracted the virus and have recovered will be used to drive a resistant response in its efforts to reduce the spread of the coronavirus and immunize its citizens. The government has also approved the use of two a
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp